ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Blood Brain Barrier Permeability in Chronic Stroke

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01203800
Recruitment Status : Completed
First Posted : September 16, 2010
Last Update Posted : February 9, 2016
Sponsor:
Information provided by (Responsible Party):
Mordechai Lorberboym Prof, Wolfson Medical Center

Brief Summary:
In this study the investigators intend to explore the long term significance of BBB disruption on the clinical course and the rate of significant recurrent ischemic events in patients with a chronic stroke.

Condition or disease
A Positive or a Negative Brain SPECT

  Show Detailed Description

Study Type : Observational
Actual Enrollment : 30 participants
Time Perspective: Retrospective
Official Title: Evaluation of Blood Brain Barrier Permeability in Chronic Stroke
Study Start Date : September 2009
Actual Primary Completion Date : November 2011
Actual Study Completion Date : November 2011



Primary Outcome Measures :
  1. Blood Brain Barrier permeability [ Time Frame: 2 years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Male and female patients at any age with a history of a large stroke in the territory of the middle cerebral artery, occurring 1-2 years ago or between 2-5 years ago.
Criteria

Inclusion Criteria:

  • Male and female patients at any age with a history of a large stroke in the territory of the middle cerebral artery, occurring 1-2 years ago or between 2-5 years ago.

Exclusion Criteria:

  • Lacunar strokes,
  • CNS lesions other than a stroke,
  • unable to perform the study.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01203800


Locations
Israel
Wolfson Medical Center
Holon, Israel, 58100
Sponsors and Collaborators
Wolfson Medical Center

Responsible Party: Mordechai Lorberboym Prof, PI, Wolfson Medical Center
ClinicalTrials.gov Identifier: NCT01203800     History of Changes
Other Study ID Numbers: 0056-09-WOMC
First Posted: September 16, 2010    Key Record Dates
Last Update Posted: February 9, 2016
Last Verified: February 2016